SCM

Soleus Capital Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 18.23%
This Quarter Est. Return
1 Year Est. Return
+18.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.28B
AUM Growth
-$45.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
98
New
Increased
Reduced
Closed

Top Buys

1 +$49.6M
2 +$45.2M
3 +$41.6M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$33.9M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$18.7M

Top Sells

1 +$27.9M
2 +$26.8M
3 +$25.2M
4
QDEL icon
QuidelOrtho
QDEL
+$24.4M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$22.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGTX icon
1
TG Therapeutics
TGTX
$5.59B
$112M 8.08%
2,846,703
+165,461
NVCR icon
2
NovoCure
NVCR
$1.58B
$98.4M 7.08%
5,521,414
+2,781,710
KRYS icon
3
Krystal Biotech
KRYS
$5.52B
$79.6M 5.73%
441,758
+83,379
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$10.3B
$76.3M 5.49%
1,079,304
+77,904
ORGO icon
5
Organogenesis Holdings
ORGO
$516M
$53.9M 3.88%
12,478,351
-6,525
GRFS icon
6
Grifois
GRFS
$6.36B
$50.4M 3.63%
7,089,822
+484,397
UTHR icon
7
United Therapeutics
UTHR
$19.1B
$47.9M 3.45%
155,394
+46,000
STAA icon
8
STAAR Surgical
STAA
$1.32B
$45.2M 3.25%
+2,562,893
PRAX icon
9
Praxis Precision Medicines
PRAX
$4B
$43.2M 3.11%
1,139,740
+896,200
BBNX
10
Beta Bionics
BBNX
$912M
$41.6M 2.99%
+3,395,341
NPCE icon
11
Neuropace
NPCE
$357M
$32.1M 2.31%
2,608,168
+175,000
NRIX icon
12
Nurix Therapeutics
NRIX
$801M
$28.8M 2.07%
2,422,833
+320,000
AXGN icon
13
Axogen
AXGN
$805M
$26.8M 1.93%
1,446,117
-1,509,826
CELC icon
14
Celcuity
CELC
$2.78B
$26M 1.87%
2,574,122
+9,035
IOVA icon
15
Iovance Biotherapeutics
IOVA
$821M
$25.9M 1.87%
7,785,000
+1,225,000
SRDX icon
16
Surmodics
SRDX
$402M
$24.1M 1.73%
789,060
+395,000
IART icon
17
Integra LifeSciences
IART
$1.24B
$23.6M 1.7%
1,072,204
-203,796
TERN icon
18
Terns Pharmaceuticals
TERN
$711M
$22.5M 1.62%
8,167,100
+24,600
MDGL icon
19
Madrigal Pharmaceuticals
MDGL
$9.58B
$22.4M 1.61%
67,500
+56,600
INSM icon
20
Insmed
INSM
$34.9B
$20.9M 1.51%
274,272
-46,000
RIGL icon
21
Rigel Pharmaceuticals
RIGL
$543M
$20.3M 1.46%
1,130,679
HOLX icon
22
Hologic
HOLX
$16.5B
$18.7M 1.34%
+302,000
ARGX icon
23
argenx
ARGX
$51.4B
$17.1M 1.23%
+28,940
MRUS icon
24
Merus
MRUS
$7.17B
$16.2M 1.17%
385,821
+73,500
NUVL icon
25
Nuvalent
NUVL
$7.01B
$15.2M 1.09%
214,357
+110,000